Hani K. Atrash
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Hani K. Atrash has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Ashley H. Hirai
Maternal and Child Health Bureau, Health Resources and Services Administration, US Department of Health and Human Services, Rockville, Maryland
1 shared publication - Benita Baker
Health Resources and Services Administration, Maternal and Child Health Bureau's, Division of Healthy Start and Perinatal Services (HRSA\MCHB\DHSPS), Rockville, MD, USA
1 shared publication - David S. de la Cruz
Health Resources and Services Administration, Maternal and Child Health Bureau's, Division of Healthy Start and Perinatal Services (HRSA\MCHB\DHSPS), Rockville, MD, USA
1 shared publication David de la Cruz
United States Department of Health and Human Services
1 shared publication- Jamelle E. Banks
Division of Epidemiology, Office of Epidemiology and Research, Maternal and Child Health Bureau, Health Resources and Services Administration, 5600 Fishers Lane, Rm 18N118, Rockville, MD, 20857, USA
1 shared publication - Johannie G. Escarne
Health Resources and Services Administration, Maternal and Child Health Bureau's, Division of Healthy Start and Perinatal Services (HRSA\MCHB\DHSPS), Rockville, MD, USA.
1 shared publication
Latest Publications
- Open Access
- 5 December 2017
- Published by Springer Nature in Maternal and Child Health Journal
- Vol. 21 (S1) , 40-48
Design and Operation of the Transformed National Healthy Start Evaluation
Purpose Improving pregnancy outcomes for women and children is one of the nation’s top priorities. The Healthy Start (HS) program was created to address factors that contribute to high infant mortality rates (IMRs) and persistent disparities in IMRs. The program began in 1991 and was transformed in 2014 to apply lessons from emerging research, past evaluation findings, and expert recommendations. To understand the implementation and impact of the transformed program, there is a need for a robust and comprehensive evaluation. Description The national HS evaluation will include an implementation evaluation, which will describe program components that affect outcomes; a utilization evaluation, which will examine the characteristics of women and infants who did and did not utilize the program; and an outcome evaluation, which will assess the program’s effectiveness with regard to producing expected outcomes among the target population. Data sources include the National HS Program Survey, a HS participant survey, and individual-level program data linked to vital records and the Pregnancy Risk Assessment Monitoring System (PRAMS) survey. Assessment Descriptive analyses will be used to examine differences in risk profiles between participants and non-participants, as well as to calculate penetration rates for high-risk women in respective service areas. Multivariable analyses will be used to determine the impact of the program on key outcomes and will explore variation by dose, type of services received, and grantee characteristics. Conclusion Evaluation findings are expected to inform program decisions and direction, including identification of effective program components that can be spread and scaled.
- 5 December 2017
- Published by Springer Nature in Maternal and Child Health Journal
- Vol. 21 (S1) , 40-48
Open AccessDesign and Operation of the Transformed National Healthy Start Evaluation
Purpose Improving pregnancy outcomes for women and children is one of the nation’s top priorities. The Healthy Start (HS) program was created to address factors that contribute to high infant mortality rates (IMRs) and persistent disparities in IMRs. The program began in 1991 and was transformed in 2014 to apply lessons from emerging research, past evaluation findings, and expert recommendations. To understand the implementation and impact of the transformed program, there is a need for a robust and comprehensive evaluation. Description The national HS evaluation will include an implementation evaluation, which will describe program components that affect outcomes; a utilization evaluation, which will examine the characteristics of women and infants who did and did not utilize the program; and an outcome evaluation, which will assess the program’s effectiveness with regard to producing expected outcomes among the target population. Data sources include the National HS Program Survey, a HS participant survey, and individual-level program data linked to vital records and the Pregnancy Risk Assessment Monitoring System (PRAMS) survey. Assessment Descriptive analyses will be used to examine differences in risk profiles between participants and non-participants, as well as to calculate penetration rates for high-risk women in respective service areas. Multivariable analyses will be used to determine the impact of the program on key outcomes and will explore variation by dose, type of services received, and grantee characteristics. Conclusion Evaluation findings are expected to inform program decisions and direction, including identification of effective program components that can be spread and scaled.
- Open Access
- 30 November 2017
- Published by Springer Nature in Maternal and Child Health Journal
- Vol. 21 (S1) , 1-3
Introduction to the Special Issue on Healthy Start
- 30 November 2017
- Published by Springer Nature in Maternal and Child Health Journal
- Vol. 21 (S1) , 1-3
Open AccessIntroduction to the Special Issue on Healthy Start
- 28 January 2015
- Published by Springer Nature in Maternal and Child Health Journal
- Vol. 19 (7) , 1435-1439
Putting the “M” Back in the Maternal and Child Health Bureau: Reducing Maternal Mortality and Morbidity
Maternal mortality and severe morbidity are on the rise in the United States. A significant proportion of these events are preventable. The Maternal Health Initiative (MHI), coordinated by the Maternal and Child Health Bureau at the Health Resources and Services Administration, is intensifying efforts to reduce maternal mortality and severe morbidity in the U.S. Through a public–private partnership, MHI is taking a comprehensive approach to improving maternal health focusing on five priority areas: improving women’s health before, during and beyond pregnancy; improving the quality and safety of maternity care; improving systems of maternity care including both clinical and public health systems; improving public awareness and education; and improving surveillance and research.
- 28 January 2015
- Published by Springer Nature in Maternal and Child Health Journal
- Vol. 19 (7) , 1435-1439
Putting the “M” Back in the Maternal and Child Health Bureau: Reducing Maternal Mortality and Morbidity
Maternal mortality and severe morbidity are on the rise in the United States. A significant proportion of these events are preventable. The Maternal Health Initiative (MHI), coordinated by the Maternal and Child Health Bureau at the Health Resources and Services Administration, is intensifying efforts to reduce maternal mortality and severe morbidity in the U.S. Through a public–private partnership, MHI is taking a comprehensive approach to improving maternal health focusing on five priority areas: improving women’s health before, during and beyond pregnancy; improving the quality and safety of maternity care; improving systems of maternity care including both clinical and public health systems; improving public awareness and education; and improving surveillance and research.
- Open Access
- 27 December 2013
- Published by Faculdade de Filosofia e Ciências in Journal of Human Growth and Development
- Vol. 23 (3) , 257-260
Childhood mortality: still a global priority
Mortality of children under-5 continues to be a global priority. In 2012, 6.6 million children under-5 died worldwide; more than half of these deaths are due to diseases that are preventable and treatable through simple, affordable interventions. In response to the United Nations’ Millennium Development Goal (MDGs) which called, through MDG4,to “reduceby two thirds the under-5 child mortality, between 1990 and 2015”, global organizations and many countries set targets and developed specific strategies to reduce child mortality and monitor progress.As a result, the number of deaths in children under-5 worldwide declined from 12.4 million in 1990 to 6.6 in 2012. Under-5 child mortality dropped in all regions of the world. However, two major challenges face the international community: The wide disparity in the risk of child death among countries, and the emerging role of neonatal death as a major component of child mortality. In order to continue the progress in reducing under-5 child mortality worldwide, current efforts must continue and new strategies need to be implemented to focus on preventing neonatal deaths as they start to represent a larger proportion of under-5 child deaths. In particular, further reduction in neonatal mortality will depend heavily on improving maternal health (MDG5).The world leaders continue to support the MDGs. In 2010, in a major push to accelerate progress on women’s and children’s health, a number of Heads of State and Government from developed and developing countries, along with the private sector, foundations, international organizations, civil society and research organizations, pledged over $40 billion in resources over the next five years.
- 27 December 2013
- Published by Faculdade de Filosofia e Ciências in Journal of Human Growth and Development
- Vol. 23 (3) , 257-260
Open AccessChildhood mortality: still a global priority
Mortality of children under-5 continues to be a global priority. In 2012, 6.6 million children under-5 died worldwide; more than half of these deaths are due to diseases that are preventable and treatable through simple, affordable interventions. In response to the United Nations’ Millennium Development Goal (MDGs) which called, through MDG4,to “reduceby two thirds the under-5 child mortality, between 1990 and 2015”, global organizations and many countries set targets and developed specific strategies to reduce child mortality and monitor progress.As a result, the number of deaths in children under-5 worldwide declined from 12.4 million in 1990 to 6.6 in 2012. Under-5 child mortality dropped in all regions of the world. However, two major challenges face the international community: The wide disparity in the risk of child death among countries, and the emerging role of neonatal death as a major component of child mortality. In order to continue the progress in reducing under-5 child mortality worldwide, current efforts must continue and new strategies need to be implemented to focus on preventing neonatal deaths as they start to represent a larger proportion of under-5 child deaths. In particular, further reduction in neonatal mortality will depend heavily on improving maternal health (MDG5).The world leaders continue to support the MDGs. In 2010, in a major push to accelerate progress on women’s and children’s health, a number of Heads of State and Government from developed and developing countries, along with the private sector, foundations, international organizations, civil society and research organizations, pledged over $40 billion in resources over the next five years.
- Open Access
- 31 October 2012
- Published by Faculdade de Filosofia e Ciências in Journal of Human Growth and Development
- Vol. 22 (3) , 396-399
THE EVOLVING ROLE OF PUBLIC HEALTH IN THE DELIVERY OF HEALTH CARE
THE EVOLVING ROLE OF PUBLIC HEALTH IN THE DELIVERY OF HEALTH CARE
- 31 October 2012
- Published by Faculdade de Filosofia e Ciências in Journal of Human Growth and Development
- Vol. 22 (3) , 396-399
Open AccessTHE EVOLVING ROLE OF PUBLIC HEALTH IN THE DELIVERY OF HEALTH CARE
THE EVOLVING ROLE OF PUBLIC HEALTH IN THE DELIVERY OF HEALTH CARE